Reply to: “Understanding HBcrAg components improves the interpretation of clinical HBcrAg assay results”
- 1 October 2021
- journal article
- letter
- Published by Elsevier in Journal of Hepatology
- Vol. 75 (4) , 998-999
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development (JP20fk0310101)
- Chugai Pharmaceutical
- Gilead Sciences
- Ministry of Education, Culture, Sports, Science and Technology (19H03640)
- Meso Scale Diagnostics
This publication has 8 references indexed in Scilit:
- Understanding HBcrAg components improves the interpretation of clinical HBcrAg assay resultsJournal of Hepatology, 2021
- Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivationJournal of Hepatology, 2021
- Capsids of hepatitis B virus e antigen with authentic C termini are stabilized by electrostatic interactionsFEBS Letters, 2019
- Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B VirionsJournal of Virology, 2018
- Antigenic Switching of Hepatitis B Virus by Alternative Dimerization of the Capsid ProteinStructure, 2013
- Hepatitis B Virus DNA-negative Dane Particles Lack Core Protein but Contain a 22-kDa Precore Protein without C-terminal Arginine-rich DomainJournal of Biological Chemistry, 2005
- New Enzyme Immunoassay for Detection of Hepatitis B Virus Core Antigen (HBcAg) and Relation between Levels of HBcAg and HBV DNAJournal of Clinical Microbiology, 2003
- Phosphorylation in the carboxyl-terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibodyJournal of Virology, 1991